Gainers
- Novo Integrated Sciences NVOS stock moved upwards by 23.5% to $0.14 during Tuesday's after-market session. This security traded at a volume of 29.7 million shares come close, making up 590.5% of its average volume over the last 100 days. The company's market cap stands at $21.2 million.
- Nexalin Technology NXL stock increased by 17.82% to $0.72. The market value of their outstanding shares is at $5.2 million. As per the news, the Q2 earnings report came out 3 days ago.
- T2 Biosystems TTOO shares moved upwards by 14.7% to $0.68. Today's trading volume for this security ended up closing at 38.1 million shares, which is 43.5 percent of its average volume over the last 100 days. The company's market cap stands at $226.1 million.
- MSP Recovery LIFW shares moved upwards by 14.19% to $0.14. This security traded at a volume of 921.3K shares come close, making up 323.6% of its average volume over the last 100 days. The company's market cap stands at $45.3 million.
- Alzamend Neuro ALZN stock increased by 7.73% to $0.33. The market value of their outstanding shares is at $31.8 million.
- Tenon Medical TNON shares moved upwards by 7.61% to $0.23. The market value of their outstanding shares is at $4.8 million.
Losers
- Impel Pharmaceuticals IMPL stock decreased by 33.3% to $0.72 during Tuesday's after-market session. The company's market cap stands at $17.0 million.
- Tempest Therapeutics TPST shares fell 7.52% to $0.62. The market value of their outstanding shares is at $7.1 million. As per the press release, Q2 earnings came out 3 days ago.
- Eloxx Pharmaceuticals ELOX stock decreased by 6.54% to $5.13. The company's market cap stands at $11.1 million.
- Aeglea BioTherapeutics AGLE shares decreased by 5.99% to $0.44. The company's market cap stands at $42.8 million. As per the news, the Q2 earnings report came out 2 days ago.
- Kezar Life Sciences KZR stock declined by 5.85% to $1.45. The market value of their outstanding shares is at $105.4 million. As per the press release, Q2 earnings came out 3 days ago.
- Cingulate CING stock decreased by 5.67% to $0.58. This security traded at a volume of 108.6K shares come close, making up 26.2% of its average volume over the last 100 days. The company's market cap stands at $8.0 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in